Illumina Partners Advance Cancer Research with Multiomics Technologies
Studies demonstrate spatial transcriptomics, 5-base sequencing, and proteomics applications in oncology diagnostics and therapeutic development.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Genomics Study Identifies 100 Genetic Causes of Vision Loss
A national study in Abu Dhabi used data from 500,000 citizens to improve early detection and prevention of inherited eye diseases.
Molecular Diagnostics
Latest
QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
Read More
Vaginal Swab Detects Molecular Signals for Endometrial Cancer
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Read More
Molecular Test Detects Bile Duct Cancer at Twice the Rate of Standard Methods
The BiliSeq molecular test detected bile duct cancer in 82% of cases—compared to 44% with standard pathology—according to a six-year, multi-institutional study.
Read More
FDA-Approved PD-L1 Companion Diagnostic Expanded to Esophageal and GEJ Carcinoma
The companion diagnostic can now help identify patients with esophageal or gastroesophageal junction carcinoma who may be eligible for pembrolizumab treatment.
Read More
CSF Liquid Biopsy Delivers 82% Clinical Impact Rate in CNS Lymphoma Cases
A retrospective study in Lymphatics reports that CSF liquid biopsy testing delivered clinical impact in 82% of CNS lymphoma cases, resolving diagnoses and informing treatment when standard methods were inconclusive.
Read More
Spatial Biology Workflow Gains New Panels and Amplification Kits
New additions to the COMET suite aim to improve flexibility and sensitivity in multiplex tissue analysis for research and preclinical development.
Read More
New IVD Assay Kits Bring Standardized NGS Workflows to Oncology Diagnostics
Powered by anchored multiplex PCR chemistry, the in vitro diagnostic offerings target fusion and variant detection for molecular pathology laboratories.
Read More
Blood Test May Help Guide Breast Cancer Treatment Decisions in Women 70 and Older
Researchers found that circulating tumor DNA testing could identify which older patients with estrogen receptor–positive breast cancer are less likely to respond to hormone therapy alone.
Read More
University of Colorado Licenses RNA Synthesis Technology to Cirena for Long-Construct Production
Cirena has licensed a University of Colorado Boulder RNA synthesis technology, enabling scalable production of high-purity, 100–400 nt RNA constructs for CRISPR, functional genomics, and RNA therapeutics research.
Read More
Baylor Genetics Adds Optical Genome Mapping and Long-Read Sequencing to Whole Genome Sequencing Test
Baylor Genetics has added optical genome mapping and long-read sequencing to its whole genome sequencing test, expanding STR analysis, enabling FMR1 methylation detection, and improving structural variant interpretation.
Read More
FDA Grants Breakthrough Device Designation to MeMed’s Capillary Blood Infection Test
The FDA has granted Breakthrough Device Designation to MeMed BV Flex, an AI-powered capillary blood test designed to distinguish bacterial from viral infections in 15 minutes using host-response biomarkers.
Read More
MyOme Adds Methylation Analysis to Whole-Genome Platform and Partners with Natera on New Test Portfolio
The Menlo Park-based company is integrating epigenetic signatures into its rare disease diagnostics offering, with the new capability set to roll out automatically in early Q2 2026.
Read More
NIH Awards $2.5 Million to Advance Eye-Based Detection of ALS Biomarker TDP-43
The Phase 2 grant supports AI-driven analysis of retinal tissue to identify disease-specific patterns linked to ALS, FTD, and LATE.
Read More
Alithea Genomics Raises $8.9 Million to Scale RNA Sequencing for Drug Discovery
Swiss company’s 1536-well technology aims to make transcriptomics cost-effective for primary drug screening and toxicology applications.
Read More
AI Liquid Biopsy Test Detects Early Liver Fibrosis and Cirrhosis
Johns Hopkins researchers have developed an AI-driven liquid biopsy that uses cell-free DNA fragmentation patterns to detect early liver fibrosis and cirrhosis, according to a study in Science Translational Medicine.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- ...
- 101